DWQA Questions › Tag: hydroxychloroquineFilter:AllOpenResolvedClosedUnansweredSort byViewsAnswersVotesCan either ivermectin or hydroxychloroquine, or both used together, reverse severe Alzheimer’s disease as exhibited, for example, by a person who cannot carry on a conversation? Or will these agents only help slow down or prevent further cognitive decline in people with early signs of illness?ClosedNicola asked 8 months ago • Healing Modalities105 views0 answers0 votesHow are the viruses causing dementia transmitted? Are dementia patients safe to be around?ClosedNicola asked 8 months ago • Extraterrestrial Interlopers106 views0 answers0 votesAre there any currently available antiviral drugs that could reverse virus-caused dementia, like ivermectin or hydroxychloroquine?ClosedNicola asked 8 months ago • Healing Modalities96 views0 answers0 votesThere have been prominent announcements from the FDA about the inadvisability and dangers of people using ivermectin to treat COVID-19. Caution about taking pill formulations intended for large animals by humans is understandable, but this seems to have the same feel as the trashing of hydroxychloroquine early and often by the medical establishment exaggeration of possible side effects and even alteration of the data in clinical trials to make it falsely look both ineffective and highly toxic. Is that planned or underway to deliberately undercut further studies of ivermectin?ClosedNicola asked 4 years ago • Coronavirus COVID-19340 views0 answers0 votesWill further clinical studies of fluvoxamine in patients with COVID-19 be suppressed by the US medical establishment as they have done for hydroxychloroquine?ClosedNicola asked 4 years ago • Coronavirus COVID-19295 views0 answers0 votesIn a preliminary study of adult outpatients with symptomatic COVID-19, patients treated with fluvoxamine, compared with placebo, had a lower likelihood of clinical deterioration. There was clinical deterioration in 0 of 80 patients in the fluvoxamine group and in 6 of 72 patients in the placebo group (absolute difference, 8.7% [95% CI, 1.8%-16.4%] from survival analysis; log-rank P = .009). The fluvoxamine group had 1 serious adverse event and 11 other adverse events, whereas the placebo group had 6 serious adverse events and 12 other adverse events. Is this a worthwhile agent for COVID-19 management? How would it compare with hydroxychloroquine or ivermectin?ClosedNicola asked 4 years ago • Coronavirus COVID-19296 views0 answers0 votesAn osteopathic physician and frequent spokesperson on the Internet says there are at least 10 ways that the SARS-CoV-2 mRNA vaccines can cause serious side effects in human recipients. Is this the case, or an exaggeration? Why is she beating this drum?ClosedNicola asked 4 years ago • Coronavirus COVID-19515 views0 answers0 votesWhat is the mechanism of Post-acute COVID-19 Syndrome, and what percentage of cases produces such symptoms?ClosedNicola asked 4 years ago • Coronavirus COVID-19365 views0 answers0 votesIs ivermectin as effective, or more effective, than hydroxychloroquine for prevention and treatment of COVID-19?ClosedNicola asked 4 years ago • Coronavirus COVID-19443 views0 answers0 votesWas the clinical study at the Henry Ford Health System for treating COVID-19 with hydroxychloroquine interfered with to reduce efficacy? There was a statistically significant benefit with both treatment groups given hydroxychloroquine, the best showing 49% less mortality with hydroxychloroquine alone, although the group receiving hydroxychloroquine plus azithromycin showed just 23.9% less mortality.ClosedNicola asked 4 years ago • Coronavirus COVID-19309 views0 answers0 votesA study just completed in the U.S. and Canada of 821 health care workers exposed to people with COVID-19 infections failed to show a statistically significant benefit of hydroxychloroquine in preventing infections (11.8% with hydroxychloroquine versus 14.3% of placebo group became ill). There was also no significant lessening of disease severity once they became symptomatic. How can the data be explained in view of your support for hydroxychloroquine use?ClosedNicola asked 4 years ago • Coronavirus COVID-19307 views0 answers0 votesThe Lancet just published a 96,000-patient registry analysis of multinational clinical data from hospitalized patients with COVID-19 comparing outcomes of four non-randomized treatment groups compared to controls: Chloroquine alone, chloroquine with a macrolide, hydroxychloroquine alone, or hydroxychloroquine with a macrolide. The main endpoints were in-hospital mortality and sustained ventricular tachycardia or ventricular fibrillation. There was no confirmed benefit of any treatment, and each of these drug regimens were associated with decreased in-hospital survival and an increased frequency of ventricular arrhythmias. Despite the fact this was not a careful randomized trial, it has been widely touted by the press, condemning the use of hydroxychloroquine as not only useless but dangerous for COVID-19 therapy. What is your interpretation of these data?ClosedNicola asked 4 years ago • Coronavirus COVID-19260 views0 answers0 votesThe New England Journal of Medicine just published a non-randomized study of hydroxychloroquine coupled with azithromycin in patients with moderate to severe COVID-19 infections, showing no benefit compared to a control group, using intubation or death as endpoints. Can you comment on the prospects for this therapy, in light of this study and your prior endorsement of this treatment?ClosedNicola asked 4 years ago • Coronavirus COVID-19323 views0 answers0 votesA viewer asks: “Is hydroxychloroquine also known as quinine that was used for years in the past?”ClosedNicola asked 4 years ago • Coronavirus COVID-19293 views0 answers0 votesA viewer asks: “Does hydroxychloroquine have advantages over quinine as an antiviral in treating coronavirus infections, and a better or worse side effect profile?”ClosedNicola asked 4 years ago • Coronavirus COVID-19303 views0 answers0 votes
Nicola